Context: Obesity, type 2 diabetes, and dental caries are all major public health problems in the United Kingdom and contribute substantially to healthcare costs. Objective: A systematic review and meta-analysis was conducted to determine the effect of product reformulation measures on sugar intake and health outcomes. Data sources: Using a combination of terms, the following databases were searched-The Cochrane Library, EMBASE, MEDLINE (Ovid), and Scopus. Additionally, multiple gray literature searches were undertaken. Data extraction: A total of 16 studies met the inclusion criteria. There were 4 randomized controlled trials, 6 studies that modeled reformulation in a country, 5 studies that modeled a different approach of reformulation, and 1 study was both a modelling study of a different approach to reformulation and a retrospective observational study. The studies were assessed for risk of bias and overall quality of evidence was rated using the Grades of Recommendation, Assessment, Development and Evaluation Working Group (GRADE) framework. Results: Results from randomized controlled trials suggest that consumption of reformulated products can reduce sugar intake and body weight. The pooled estimates were À11.18% (95% confidence interval [CI], À19.95 to À2.41; P < 0.00001) for changes in percentage of sugar intake, À91.00 g/day (95%CI, À148.72 to À33.28; P< 0.00001) for changes in sugar intake in grams per day, and À1.04 kg (95%CI, À2.16 to À0.08; P¼ 0.0002) for changes in body weight. However, the quality of the evidence was very low. Results from the other studies suggested that reformulation can reduce sugar intake and improve health. Much of the evidence draws on modeling studies. Conclusions: This systematic review and meta-analysis suggests that product reformulation to reduce sugar content could reduce sugar intake in individuals and thus improve population health. These findings provide an important starting point for ongoing work on sugar reformulation.
INTRODUCTION
Obesity, type 2 diabetes, and dental caries are all major public health problems in the United Kingdom [1] [2] [3] [4] [5] [6] [7] and contribute substantially to healthcare costs. 8 It is recognized that consumption of excessive free sugars ("sugar") is associated with these conditions. [9] [10] [11] [12] [13] [14] In July 2015, the Scientific Advisory Committee on Nutrition (SACN) recommended that the average intake of sugar across the UK population should not exceed 5% of total energy intake. 10 This is in line with the World Health Organization's (WHO) new guidelines on sugar intake. 15, 16 As of 2014, average intakes of sugar in the United Kingdom exceeded recommendations in all age groups. 17 Children have a 3-fold higher intake of sugar than that recommended; the average intake was 54 g (13% of total energy) and 73 g (15%) per day in those aged 4-10 years and those aged 11-18 years, respectively. 17 A number of population-level interventions have been proposed, including pricing interventions, food procurement interventions, restrictions on marketing to children, on-pack nutrition information, information campaigns, and product reformulation. 18 These interventions can potentially reduce population sugar intake, however, in recent years product reformulation has gained prominence as a potential cost-effective intervention, particularly in the United Kingdom. 8, 19 Product reformulation in whole jurisdictions (eg, countries) are efforts to lower the "unhealthy" components (eg, saturated fat, trans fats, sugar, salt) of products at the time of production without worsening the profile of other ingredients (eg, increasing calorie content). 20 The reformulated products should replace existing product (eg, the same brand of drink with less sugar). This approach does not rely on substantial behavioral change on the consumer's part.
Reformulation has been proven to be effective at reducing salt intake in the United Kingdom. The key to the success of the UK salt reduction program has been the setting of incremental targets for each food group with a specified timeframe to complete reformulation, using maximum and average or sales-weighted average targets. 21 Because the reduction in salt has been gradual and progressive, the UK population has adjusted to the taste of lower salt concentrations, without adding salt at the table. 22 The average salt intake for adults fell from 9.5 g in 2000-2001 to 8.1 g in 2011; this was accompanied by a fall in population blood pressure and mortality from stroke and coronary heart disease. 23, 24 Given the progress made with the salt reduction program in the United Kingdom, it has been proposed that sugar consumption can be reduced through a similar systematic, unobtrusive, and gradual reformulation program for manufacturers, 19 particularly because most of the sugar in the diet comes from manufactured products, with the food and drink industry representing an important leverage point for reformulation.
Because sugar reformulation is a relatively new area that has undergone a recent surge in research, it was deemed necessary and most appropriate to collate all of the evidence available using a systematic methodology to demonstrate the state of the evidence as well as the gaps that can be addressed by researchers and policy makers. Therefore, the aim of this study was to systematically review the evidence on the effect of product reformulation measures to reduce sugar intake and improve health outcomes.
METHODS
The study design adhered to the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA) 2015 statement. 25 The protocol has been previously published. 26 The guiding question of this review was, "What is the effect of reformulation on sugar intake and health?"
Inclusion and exclusion criteria
The criteria for study eligibility in this review, including population, intervention, comparison, outcome, type of study, and setting (PICOTS) elements, are described in Table 1 . Studies published between 1990 and early 2016 were included. This is because publications about reformulation, particularly salt reformulation, began to appear in the literature in the early 2000s; therefore, starting the search from 1990 guaranteed the capture of any papers published before 2000. Studies were excluded if they were non-English language studies, had no relevant outcome measures, or involved interventions with short durations (< 8 wk).
Search strategy
Electronic databases were systematically searched using a combination of terms tailored to each database.
An initial limited search of EMBASE was undertaken; this was followed by an analysis of the text words contained in the titles and abstracts. A second search using all identified keywords and index terms was undertaken across all included databases. The databases searched included the Cochrane Library, EMBASE, MEDLINE (Ovid), and Scopus. The reference lists of key articles that matched inclusion criteria were searched by hand to identify any further relevant references, which were subject to the same screening and selection process.
Gray literature searches were also undertaken using the broad search terms "sugar" and "food" or "drink" and "reduction" or "reformulation." These searches included key government and organization websites, as well as general searches in Google.
Screening and data extraction
All papers identified from the initial electronic search process were imported into an Endnote library, and duplicates were removed. The eligibility criteria were applied to the results, and all identified references were screened using a 2-stage approach. The first stage involved 2 reviewers independently reviewing the title and the abstract. In the second stage, the full-text versions of the shortlisted papers were extracted and assessed by the lead author. The number of excluded studies (including reasons for exclusion) was recorded at each stage. A standardized data extraction form was developed and piloted prior to its use.
Meta-analysis of randomized controlled trials
For each trial, the mean effect on sugar intake and body weight was calculated. For crossover trials, the mean effect was the difference in outcomes between the end of the reduced sugar period and the end of the sugar (ie, control) period. For parallel trials, the mean effect was the difference between the 2 groups in the change in outcomes from baseline to the end of follow-up.
The variance of the mean effect for outcomes in each trial was calculated. This was derived from standard deviations of paired differences between baseline and the end of follow-up for each group in a parallel trial or between the 2 diet periods in a crossover trial.
To assess the mean effect sizes, the data were pooled using the inverse variance method in a random-effects meta-analysis. The I 2 test was used to examine heterogeneity, with I 2 > 50% considered to be important. 27 
Assessment of risk of bias in included studies
For randomized controlled trials (RCTs), the Cochrane risk of bias tool 28 was used. Tools for assessing risk of bias in RCTs are well described, but much less attention has been given to similar tools for observational studies. 29 A risk-of-bias tool adapted for nonrandomized controlled studies on population-level interventions, which has been used by 2 recently published Cochrane systematic reviews on population-level interventions, 18, 30 was chosen. It was deemed the most appropriate tool because it was adapted from the gold-standard Cochrane risk-of-bias tool.
Some of the studies included in the systematic review were modeling studies. These studies are based on many assumptions; therefore, an adapted Cochrane risk of bias was not appropriate. Hence, only the strengths and limitations of those studies were discussed.
Assessment of quality of evidence
The overall quality of evidence was rated using the Grades of Recommendation, Assessment, Development and Evaluation Working Group (GRADE) framework, 31 which is Cochrane's recommended approach for grading the quality of evidence and the strength of recommendations. When using GRADE, evidence is rated not by study but across studies for specific outcomes. It is based on 5 considerations: risk of bias, imprecision, inconsistency, indirectness, and publication bias. There are four possible GRADE ratings: high, moderate, low, and very low. 32 Randomized controlled trials studies start at a GRADE rating of high, which may be decreased. The grade may be decreased by 1 or (if very serious) 2 levels in the following circumstances: serious or very serious limitations to study quality; important inconsistency; some or major uncertainty about directness; imprecise or sparse data; or high probability of reporting bias. 31 Observational studies start at a GRADE rating of low, which may be increased or decreased. The grade may be increased in the following circumstances: strong evidence of association based on consistent evidence from > 2 or more observational studies with no plausible confounders (þ1); very strong evidence of association based on direct evidence with no major threats to validity (þ2); evidence of a dose-response gradient (þ1); or all plausible confounders with reduced effect (þ1). 31 GRADE rating was not applied to modeling studies, but the outcomes assessed by the modeling studies were added in a narrative form to the summary of findings table.
RESULTS
A total of 16 studies met the inclusion criteria. There were 4 RCTs, 6 studies that modeled reformulation in a country, 5 studies that modeled a different approach of reformulation, and 1 study both modeled a different approach to reformulation and was also a retrospective observational study (Figure 1 ). The results are summarized in Table 2 . [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] As required by the GRADE method, the evidence was graded as very low for the RCTs due to the lack of blinding, inconsistency, indirectness, and imprecision (as a result of low participants in pooled RCTs). For the 1 observational study, the grade was kept as low because there was only 1 observational study and the effect was small. The outcomes assessed with modeling studies were not graded.
Randomized controlled trials
Four RCT publications assessed the effect of sugarreformulated products over a period of 8-10 weeks (Table 3) . [33] [34] [35] [36] Two of the publications were based on the same trial. Of the 3 trials, 2 used paralleled comparisons, [34] [35] [36] and 1 used crossover design.
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Figures 2-4 [33] [34] [35] [36] show the change in sugar intake (%), sugar intake (g/d) and body weight in individual trials included in the meta-analysis and the mean effect size. The pooled estimates of reduction were À11.18% (95% confidence interval [CI], À19.95 to À2.41, P < 0.00001) in percentage of sugar intake, À91.00 g/day (95%CI, À148.72 to À33.28; P < 0.00001) in sugar intake in grams per day, and À1.04 kg (95%CI, À2.16 to À0.08; P ¼ 0.002) in body weight.
Modeling of reformulation
Six modeling studies assessed the impact of reducing sugar intake through reformulation on either population sugar intake [38] [39] [40] [41] ( Figure 5 ) [38] [39] [40] [41] [43] [44] [45] [46] [47] [48] and/or health outcomes 37, 38, 42 (Table 2 ). The studies focused on 2 countries: the United Kingdom [37] [38] [39] and France. [40] [41] [42] Three studies were based on the UK (England) population (Table 4 37-39 and Figure 5 ). All of the studies assumed a reduction in sugar intake and/or an improvement in health outcomes.
Three studies were based on the French population (Table 5 40-42 and Figure 5 ). Two studies assessed the impact on sugar intake, 40, 41 and 1 assessed the impact on both intake and health outcomes. 42 
Different reformulation approaches
The search retrieved several different approaches to reformulation. The different approaches are described as 1) cap and trade (1 simulation), 2) Choices program 
Overweight and obesity
One modeling study found reformulation of soft drinks reduces overweight by 1.0% (from 35.5% to 34.5%; 0.5 million adults) and obesity by 2.1% points (from 27.8% to 25.7%; 1 million adults). The same modelling study found if fruit juices were excluded, the reduction will be lower, overweight will be reduced by 0.7% (0.3 million) and obesity by 1.7% (0.8 million) Another study found that reformulation through a cap-and-trade intervention would reduce obesity by 1.7% (95%CI, 0.9-2.4) over 20 y Under the "optimistic" scenario simulated, in which consumers continued consuming their preferred product after its reformulation (rather than switching to another product with the nearest sugar content), obesity was reduced by 3.2% (95%CI, 2.4-4.0) (2 modeling studies) -
Glycemia and insulinemia
Sugar group resulted in significant increases of postprandial glycemia and insulinemia compared to reformulated group
One modeling study found that reformulation of soft drinks could prevent about 274 000-309 000 cases of obesity-related type 2 diabetes over the 2 decades after the predicted reduction in bodyweight is achieved. The same modelling study found, if fruit juices were excluded, 221 000-250 000 cases will be prevented (2 modeling studies) -
(4 simulations), and 3) industry-led reformulation (1 that was both a simulation and observational). The modeling studies that reported reduction in sugar intake in grams are illustrated in Figure 5 .
Cap and trade. Basu and Lewis 43 suggested a cap-andtrade approach to reformulation. They provided initial permits to all manufacturers (year 2015) at no cost. The permits to each manufacturer equalled the mean baseline sugar emissions level. They then gradually lowered the cap in each subsequent year; they simulated a 20% reduction over 20 years (at a rate of 1% annually from the starting level).
In the less optimistic scenario, Basu and Lewis, 43 estimated that calorie intake may fall by 31 kcal/person/ day (95%CI, 29-33) at the 20-year mark, which would equate to 7.8 g of sugar. In a sensitivity analysis, where manufacturers passed on the cost of sugar emissions permits to consumers rather than absorbing the costs themselves, calorie intake may fall by 36 kcal/person/ day (95%CI, 33-39), which would equate to 9 g of sugar.
The greater decline resulted from consumers switching There was serious concern over the heterogeneity of the randomized controlled trials because the v 2 P value was significant and the I 2 > 50%. d Randomized controlled trials are not an entirely suitable assessment of a whole population reformulation intervention because the duration of trials were short. e The number of participants was low.
to lower-sugar alternatives when high-sugar products became more expensive. This approach was estimated to reduce the prevalence of obesity by 1.7 percentage points (95%CI, 0.9-2.4; a 4.6% decline) and the incidence of type 2 diabetes by 21.7 cases/100 000 people (95%CI, 12.9-30.6; a 4.2% decline) over 20 years. Racial/ethnic minorities may experience the largest declines in obesity prevalence and type 2 diabetes incidence. Under the "optimistic" scenario simulated, in which consumers continued consuming their preferred product after its reformulation (rather than switching to another product with the nearest sugar content when their preferred product was reformulated), obesity prevalence could be reduced by 3.2 percentage points (95%CI, 2.4-4.0), and type 2 diabetes incidence could be reduced by 37.7/100 000 people (95%CI, 22.4-53.1).
Choices program. The Choices program's 2 main aims were to encourage the food and drink industry to reformulate and/or develop new healthier products and to help consumers make healthier choices by recognizing the Choices logo. 49 The criteria were developed and set for the Dutch market by an independent scientific committee advising the Choices Foundation Board. 50 Manufacturers used the Choices logo if their products met the Choices criteria and were approved. The committee periodically evaluates the product criteria so as to keep up-to-date with the latest scientific and reformulation developments. After each review, a transition period is given during which manufacturers can reformulate to align their products with the new criteria and continue to use the logo. 49 Four studies modeled the potential impact of the Choices program on the Dutch populations' sugar intake, among other nutrients (Table 6) . [44] [45] [46] [47] One of the studies also modeled the potential impact of the Choices program on diets in Greece, Spain, the United States, Israel, China, and South Africa. 46 None of them evaluated the potential impact of nutrient intake changes on health outcomes. All of the studies showed the Choices program could encourage reformulation and reduce sugar intake from current levels. Figure 5 shows the reduction in sugar intake in the models that reported sugar intake in grams per day.
Industry-led reformulation. Another approach to reformulation is industry-led reformulation. Only 1 study evaluated the effect of industry-led sugar-reformulation. levels of sugar sold via reformulated products pre-and post-reformulation and 2) calculating daily sugar intakes of Irish subpopulations at pre-and postreformulation. The nutrient composition levels for sugar, as well as energy, total fat, saturated fat, and/or sodium, were submitted for nearly 600 products from the 14 FDII members.
This analysis generated 2 scenarios estimating the impact of reformulation on the 4 subpopulations. Scenario A assumes all companies across the food and drink sector with similar products reformulated in a similar way to the 14 FDII member companies involved (optimistic); this was the modeling part of the study. Scenario B assumes only the 14 FDII members conducted their reported reformulation, thereby estimating the minimum impact of reformulation in Ireland (conservative); this was the observational part of the study.
The results showed that during the 7 years (2005-2012) covered by the research, sugar content fell by 14%. In individuals who consumed reformulated products, the mean daily sugar intake was reduced by 2.06% (observed) to 7.70% (modeled) in adults, 1.36% (observed) to 7.44% (modeled) in teenagers, 1.21% (observed) to 13.56% (modeled) in children, and 1.07% (observed) to 9.84% (modeled) in preschoolers. Table 1 shows the modelled reduction in sugar (g) intake in the Irish population's daily total diet.
Risk of bias of included studies
The overall risk of bias in the RCTs was high due to ineffective blinding. However, insufficient information was provided to show whether there was sufficient allocation concealment in the trials. (Table S1 in the Supporting Information online).
Observational studies
The Cochrane risk-of-bias tool adapted for nonrandomized controlled studies on population-level interventions showed the overall risk of bias was high for the single study 48 in this systematic review that included a retrospective observational study component (Tables S2 and  S3 in the Supporting Information online).
DISCUSSION
This review assessed the impact of reformulation on sugar intake and health outcomes. Although the number of studies was limited and the types of studies and the types of interventions are extensively heterogeneous, there is some indication that sugar reformulation can reduce sugar intake and hence improve health outcomes. Because the types of studies and the types of interventions were heterogeneous, the groups of studies are each discussed separately.
Randomized controlled trials
Meta-analysis of RCTs showed sugar intake and body weight were reduced after reformulation. However, there was extensive heterogeneity among the trials and a number of factors may have contributed to the results. Sugar and energy intake. The amount of energy and sugar consumed in the sugar (or control) groups versus the sugar-reformulated groups in the trials varied. The 2 trials that showed no effect on health outcomes (weight) had a lower net difference in energy intake by the end of trial compared with the 2 trials that had an effect on energy intake and, therefore, health outcomes. In the Markey et al. 36 and Gatenby et al. 33 trials, the net differences between the 2 groups were 181 kcal/day and 52 kcal/day, respectively, whereas in the trial conducted by Raben et al., 34 the net differences between the 2 groups was 492 kcal/day.
Administration. The way the products were administered to the participants was very different across trials. This may have affected the potential impact on the participants. In the Markey et al. 36 trial, participants were provided with sufficient study products from a choice of 7 drinks and 19 foods. The participants were also asked to replace habitually used sugar and condiments with those provided by the investigators ad libitum throughout the study periods. Similarly, in the trial by Raben et al. 34, 35 the participants received products containing sugar and similar reformulated products containing noncaloric sweeteners (in similar amounts to sugar group). In contrast, in the trial by Gatenby et al., 33 the participants were told to seek commercially available reformulated products and record what they consumed. The participants knew very well they were consuming reduced-sugar reformulated products over their regular products. The difference in the way the products were administered to participants may have led to differences in energy compensatory behaviors.
Other differences in the trials, such as blinding, and underreporting in outcome measures (eg, sugar intake), may have influenced the outcomes. Although there were attempts in 2 trials 34, 36 to blind participants to whether they were on a sugar/control product diet versus a reformulated product diet, the blinding may have been ineffective. In the Markey et al. 36 study, 83% of the participants correctly identified the sugar products and the reformulated products.
Moreover, in the Raben et al. 34, 35 trial, the participants were told that they received products containing noncaloric sweeteners. At the end of the study, participants in the reformulated group believed this, but participants in the sugar group guessed to some extent the true content of their products. This could have influenced the participant's eating behavior so that participants in the sugar group would have eaten less of their own products and participants in the reformulated group would have eaten more of their own products. Therefore, the net difference in calorie intake between sugar and reformulated groups may have been smaller than intended. All of the trials relied on food diaries as a key outcome measure because there is no biomarker to assess sugar intake. Participants tend to underestimate and underreport their intake of high fat, salt, and sugar products; therefore, the reported intakes may have underestimated the real sugar intake and ultimately the total energy intake. [51] [52] [53] [54] This outcome measure is also known to place a burden on participants, and indeed there was evidence of reduced reporting toward the end of the Gatenby et al. 33 trial. Further to the concerns above, GRADE allowed for the assessment of the RCTs' quality of evidence. Due to the lack of blinding and allocation, inconsistency, and imprecision (as a result of low participants in pooled RCTs), the quality of evidence was very low.
In summary, a limited number of RCTs addressed the use of reformulation to reduce sugar intake and assess the impact on health outcomes. The mean effect suggests reformulation has an impact on sugar intake and body weight. However, long-term RCTs on dietary manipulation and impact on health outcomes may not be practical to perform due to expense, adherence, and legality. 41 Modeled different food reformulation scenarios for breakfast cereals, biscuits and pastries, and breadbased products to assess impact on population intake of sugar, fat, and salt
In breakfast cereals scenarios 1, 2, and 3, the amount of sugars supplied to the market would be reduced by 993-3830 tons. At the individual intake level for the average child consumer of breakfast cereals, this represents a 2.6%-9.1% decrease in the intake of sugars provided by these products. The daily intake of sugars provided by breakfast cereals decreased by 0.4-1.4 g Biscuits and pastries scenarios 1, 2, and 3 decreased the amount of sugars supplied to the market by 1111-8888 tons. In the average child consumer of biscuits and pastries, this change represents a decrease in sugar intake by 0.5%-4.2%. In the children, the 3 scenarios decrease the daily intake of sugar by 0.03-0.22 g For adults who are high consumers of bread-based products, the simulation led to a 0.13-0.63 g decrease in the daily intake of sugar Leroy et al. (2015) 42 Modeled reformulation scenarios on sugar intake and health outcomes
The number of deaths avoided by reducing sugar was 746 deaths per year 
Modeling of reformulation
All of the modeling studies suggest reformulation can reduce sugar intake [38] [39] [40] [41] [42] and improve health outcomes. 37, 38, 42 The results provide useful insight, revealing the extent to which reformulation could contribute to improving health, even in the absence of changes in individual's behavior. However, the results must be considered with caution given the uncertainties surrounding modeling studies.
There are known limitations to national dietary survey data, which are used extensively in modeling studies. Many studies show that dietary surveys relying on self-reported intake data are prone to errors of recall. [51] [52] [53] [54] [55] [56] [57] Therefore, any studies of associations with health based on self-reported dietary intake data may potentially underestimate the effect of reformulation but also underestimate the interventions needed to deal with excessive sugar intake.
Moreover, there are concerns related to the type of food composition data used. For example, generic food composition data do not include many branded and new products, meaning that several products are averaged to 1 nutrient composition, which may not represent the products consumed. Indeed, studies have shown that very similar products can have a wide variation in nutrient levels, particularly in sugar content. 58 Also, nutrient data may not have been correctly measured or calculated. For instance, the definition of free sugars excludes other sugars such as lactose and intrinsic sugars in fruit and vegetables. However, there are no verified tests to distinguish the different types of sugars, and current labeling requirements for total sugars do not distinguish the different types. This can add a layer of complication when estimating the effect of reformulation. Also, this can act as a disincentive to manufacturers attempting to reformulate when their efforts may be confounded by the presence of milk, fruit, and vegetables.
Nevertheless, generic food composition databases are the best open source of nutrition information available for a wide range of products.
Some modeling studies may have underestimated the potential impact of reformulation. In the Ma et al. 38 study several separate analyses were conducted the results suggested that the main findings were conservative. The authors also estimated sugar-sweetened drink intake more accurately by combining sales and intake data to overcome the prevalent issue of diet underreporting, which has rarely been considered in similar studies. 59, 60 Although they tried to correct for underreporting, the results are still likely to have underestimated the effect of reformulation. However, some models may have overestimated the impact because in foods, unlike drinks, reformulation in practice can be more complex than simulated. 61 At the same time, most of the modeling studies assessed the initial impact of reformulation and not Abbreviations: BMI, body mass index; CI, confidence interval. *It was hypothesized that consumers may compensate for the reduction in energy intake by eating more foods with lower energy density. Therefore, when foods were replaced with foods with lower energy, a multiplication factor was applied, so that the total amount of energy consumed was the same as the energy delivered by the replacement food.
subsequent reformulation. Therefore, the long-term impact of reformulation may have been underestimated. Furthermore, it is likely that once the products with the lowest level of sugar are reformulated, some products that were initially more nutritious will also be reformulated to maintain product differentiation. Modeling studies did not consider practical concerns with reformulation, such as whether the intervention will be implemented by a government jurisdiction on a voluntary or mandatory basis. There are several examples of programs implemented by governments that sought to reduce the population's sugar intake as part of a wider intervention to improve population diets, including programs in England, 62 the Netherlands, 63 France, 64 and Australia. 65 Most of these programs are voluntary, and therefore their effectiveness has been questioned. 40, [65] [66] [67] [68] The concern seems to revolve around lack of compliance from manufacturers; progress maybe slowed down because there are no consequences for non-compliance. Nevertheless, the results from the modeling studies are promising.
Different approaches of reformulation
All of the modeling studies of different reformulation approaches show a reduction in sugar intake and/or improvement in health outcomes. However, all of the concerns raised previously in relation to the limitations of modeling studies would apply to the Basu and Lewis 43 modeling study and the Choices program studies. [44] [45] [46] [47] Moreover, the Choices program and health logo/ label initiatives in general are often implemented on a voluntary basis. Therefore, not all manufacturers will reformulate their products to comply with the criteria. 69 Furthermore, studies that assess only products with such logos often do not collect data on how many less healthy products or those not meeting the logo criteria were introduced during the same time frame, limiting their ability to evaluate the overall supply chain. 70 Logos/labels are intended to enable consumers to make informed choices, but this can only work if consumers understand the information they are provided. Also, the need to see reformulation permeate the entire supply chain argues against the use of logos/labels, which are used by manufacturers to promote their products. 71 Nevertheless, in the absence of populationlevel reformulation interventions, logos/labels can encourage some reformulation if the criteria are strict.
Another approach is industry-led reformulation, which has been shown to reduce sugar intake. Many manufacturers around the world claim to be reformulating. 72 However, when their reformulation plans are closely assessed, it is found that what is meant by "reformulation" is actually creating new reduced-sugar products, which is new product development. New product development is not reformulation; in such cases, the manufacturers are not reformulating a product to replace an existing one.
Strengths and limitations
This review is the first to investigate the impact of sugar reformulation on intake and health outcomes and grade the quality of the evidence. The review captured a wide range of studies because the inclusion criteria was broad.
However, several limitations must be acknowledged. The limitations of the findings are those inherent to the primary research on which they are based, notably inadequacy of dietary intake and food composition data, variation in the interventions, and the limited number of trials and studies.
The exclusive reliance on English-language studies may have not represented all of the evidence available and contributed to a language bias.
The terms used for the search strategy are one of the most important aspects of searching through the literature. It is crucial to capture as many ways to express an idea or concept as possible to include as many relevant publications as possible. Because the term "reformulation" is open to interpretation, the terms used in the search strategy can probably be improved to retrieve more studies on reformulation. Furthermore, the search focused on sugar intake, but there are studies that focused on energy and calorie intake; therefore, not including such terms may have limited the evidence retrieved.
The quality of modeling studies was not assessed because there are no formal assessment tools for them.
Ultimately, the number of studies on sugar reformulation are limited, with high risk of bias and an overall grade of low to very low quality; thus, drawing conclusions on study outcomes/effects was difficult.
CONCLUSION
The findings of this review suggest that sugar reformulation can be beneficial in reducing sugar intake and improving health outcomes. Much of the evidence draws on the potential benefits of population-level interventions through modeling, and these studies suggest there are health gains. This review provides an important starting point for ongoing work on sugar reformulation.
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